Proteomics

Dataset Information

0

Mapping of nanobody binding sites on human LRRK2 by CX-MS


ABSTRACT: As part of an in-depth characterization of nanobodies directed against the human Leucine-rich repeat kinase 2 (LRRK2), epitopes of the nanobodies bound to LRRK2 were mapped by chemical crosslinking combined with mass spectrometry using the CID-cleavable crosslinker disuccinimidyl sulfoxide (DSSO).

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Parkinson's Disease

SUBMITTER: Johannes Gloeckner  

LAB HEAD: Christian Johannes Gloeckner

PROVIDER: PXD030063 | Pride | 2022-02-27

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
GUA3120-S02_13606_fraction1.raw Raw
GUA3120-S03_13606_fraction2.raw Raw
GUA3120-S06_14133_fraction1.raw Raw
GUA3120-S07_14133_fraction2.raw Raw
GUA3120-S08_14259_fraction1.raw Raw
Items per page:
1 - 5 of 26
altmetric image

Publications


Mutations in the gene coding for leucine-rich repeat kinase 2 (LRRK2) are a leading cause of the inherited form of Parkinson's disease (PD), while LRRK2 overactivation is also associated with the more common idiopathic form of PD. LRRK2 is a large multidomain protein, including a GTPase as well as a Ser/Thr protein kinase domain. Common, disease-causing mutations increase LRRK2 kinase activity, presenting LRRK2 as an attractive target for drug discovery. Currently, drug development has mainly fo  ...[more]

Similar Datasets

2024-04-23 | PXD046634 | Pride
2023-03-11 | PXD038629 | Pride
2020-02-17 | PXD014759 | Pride
2023-04-24 | PXD035844 | Pride
2022-08-17 | PXD031421 | Pride
2021-09-24 | PXD027611 | Pride
2023-03-31 | PXD040006 | Pride
2022-12-19 | PXD033748 | Pride
2022-01-12 | PXD026191 | Pride
2020-07-28 | PXD014337 | Pride